|Cardiovascular Health Announcements|
March 23, 2017
Frequently Asked Questions (FAQ): Request for Proposals-Training Module Development to Support Increased Utilization of National Databases for Cardiovascular Health Research and Surveillance.
March 1, 2017
The National Association of Chronic Disease Directors (NACDD), in coordination with CDC’s Division for Heart Disease and Stroke Prevention, is pleased to announce an opportunity for teams to participate in a program designed to accelerate team-based care to manage high blood pressure, through the use of the Pharmacists’ Patient Care Process (PPCP) and Collaborative Practice Agreements (CPA) resource guides developed by CDC and pharmacy partners.
The deadline for the application is April 7, 2017.
News: 1305/1422 Epidemiology and Evaluation Collaborative (EEC) Celebrates 100 State Members!
NACDD’s peer learning group for epidemiology, surveillance, and evaluation staff in 1305 and 1422 programs has ballooned in the last year, with the current participation list at 100 members. Funded through the Division for Heart Disease and Stroke Prevention’s Program Development and Services Branch, monthly meetings with active discussion now average over 50 participants. Current topics on evaluation and performance measures drive the agendas, and the meetings are facilitated by members. Brittany Brown (UT), Liz Gebhart (NE), and Paul Meddaugh (VT) comprise the EEC Leadership and help to plan meeting agendas. Between meetings, EEC members connect by email to share resources, such as assessment tools, strategies for calculating performance measures, and to clarify CDC guidance. States often receive responses from several states within a few days and sometimes within a matter of hours.
A factor contributing to EEC’s success is the regular participation of CDC 1305 staff on EEC calls. The Division for Heart Disease and Stroke Prevention’s Applied Research and Evaluation Branch (AREB) leads evaluation for 1305. The 1305 and 1422 lead evaluators attend EEC calls, where they can provide immediate answers to questions and updates on forthcoming resources and deadlines. CDC’s Epidemiology and Surveillance Branch also sends a representative to meetings to help the branch stay informed of ongoing surveillance and epidemiology needs in states.
Outgoing Chair Rachael Austin (NY) explained how EEC has shaped her work as an epidemiologist and evaluator:
When CDC released the 1305 FOA in 2013, I found myself transitioning from the role of a diabetes epidemiologist to the lead epi/evaluator for all of New York’s D3/D4 activities. I had no idea where to start, and the idea of health systems work overwhelmed me. Luckily, our HDSP program manager at the time suggested that I join EEC to connect with other evaluators in the field. That remains one of the best pieces of advice I’ve ever received. EEC became somewhat of a home for me– a safe place to discuss barriers and challenges to data collection and reporting, share tools and resources and develop solutions to common questions/issues. It also allowed me to network and develop friendships with my peers from all over the country…I recommend EEC participation to all of our new New York State staff working on 1422 and 1305. There has been no better venue to collaborate, learn and share best practices with other chronic disease epi/evals than EEC.”
EEC meets on the second Wednesday of the month at 2pm ET. Meetings are open to anyone interested in 1305/1422 data discussions. For more information about EEC, visit our webpage and contact MaryCatherine Jones, Public Health Consultant, at email@example.com.
December 2, 2016
NACDD invites chronic disease/health promotion directors and staff to apply for a leadership development, mentoring, and learning opportunity called Generate Educate Activate Respond (GEAR) Groups. GEAR Groups are part of a professional development and leadership program in NACDD to provide learning incubators on various crosscutting topics of interest to further advance leadership, mentoring and expand opportunities for networking with other public health professionals at state health departments.
This prestigious opportunity is a selective process by application (due January 6, 2017) at the following link: https://www.surveymonkey.com/r/2017GEARgroupapp.
The focus of the 2017 round of NACDD GEAR Groups will be on communicating the role and value that public health has in achieving the Triple Aim. The five GEAR Groups described below will look through the lens of health equity and CDC’s four chronic disease domains to discuss how public health can more effectively communicate the value of their chronic disease prevention and control efforts and outcomes to a variety of stakeholders.
GEAR Groups are offered in five topic areas based on data collected from NACDD members and Board members. The five groups are:
GEAR Group 1: Communicating the Value of Public Health through Data and Surveillance.
GEAR Group 2: Communicating the Value of Public Health through Environmental Approaches.
GEAR Group 3: Communicating the Value of Public Health through Health Systems.
GEAR Group 4: Communicating the Value of Public Health through Community-Clinical Linkages.
GEAR Group 5: Communicating the Value of Public Health through Health Equity.
To learn more and apply, visit: http://www.chronicdisease.org/?page=GEAR_Groups
For more information, contact Jennie Hefelfinger at firstname.lastname@example.org
October 25, 2016:
The National Forum for Heart Disease and Stroke Prevention held its 14th annual meeting October 19th in Washington DC. The focus this year was on bridging clinical and population health, and included many speakers to address this hot topic. The National Forum also took time to recognize key leaders for their work in heart disease and stroke prevention. Award recipients included:
The American Heart Association, the National Forum, and NACDD held a reception the evening before to celebrate the 10th anniversary of the formation of the Centers for Disease Control and Prevention's Division for Heart Disease and Stroke Prevention. CDC staff who were instrumental to the formation of the division were acknowledged, and remarks were given both by the Division's first director, Darwin R. Labarthe, MD, PhD, and the current acting director, Cathleen Walsh, DrPH, MSPH.